Company intelligence / Profile preview

MELTIN MMI

Chuo-ku, Tokyo, Japanmeltin.jp ↗

Ownership: Private
Development stage: Other

Overview

The company’s flagship product, the MELTz Hand Rehabilitation System, has received Japanese medical device certification and supports neurorehabilitation for patients with hand paralysis. Early clinical use focuses on enabling patients to relearn movement through neuroscience-based feedback. Other programs include advanced avatar robots in prototype stages.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (robotic neurorehabilitation)AI-based assistive technology (bio-signal processing)
Industry: Assistive Medical Devices

Partnerships

Sumitomo Pharma/Sumitomo Dainippon PharmaSBI Investment Co., Ltd.Dai-Ichi Life Insurance Company Ltd.Research Products Development Company (RPDC), Saudi Arabia – joint development/commercialization of remote control robot tech and medical robotics

Beyond the preview

Go deeper on MELTIN MMI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MELTIN MMI.

Explore the full profile